| 產品名稱 |
Human rhinovirus 41 |
| 商品貨號 |
B161711 |
| Classification |
Picornaviridae, Rhinovirus, Human rhinovirus A |
| Deposited As |
Rhinovirus 41 |
| Agent |
Human rhinovirus 41 |
| Strain |
56110 |
| Applications |
HeLa cells used in passage of virus prior to 1993 believed to be contaminated with Mycoplasma orale and Mycoplasma hyorhinis. Respiratory research |
| Positive for Mycoplasma |
Yes |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
Throat, adult male |
| Product Format |
frozen |
| Storage Conditions |
-60°C |
| Comments |
HeLa cells used in passage of virus prior to 1993 believed to be contaminated with Mycoplasma orale and Mycoplasma hyorhinis. Virus is contaminated with Mycoplasma, which can be eliminated from viral stock by treatment with chloroform or ether. Size estimated to be approximately 14 nm by ultrafiltration. Growth not inhibited by IUDR. Stabilized by 1 M MgCl(2). |
| Effect on Host |
Yes, in vitro effects: Cytopathic effects in tissue culture CPE |
| Recommended Host |
H1-HeLa cells (ATCC CRL-1958) Host of Choice: WI, HeLa, MRC-5 cells Host Range: HD, HEK, stable human cell cultures and also MkK cells for some strains WI-38 cells (ATCC CCL-75); HeLa cells (ATCC CCL-2); other human cells |
| Growth Conditions |
Duration: 1-7 days |
| Name of Depositor |
MA Mufson, VV Hamparian, RM Conant |
| Source |
Throat, adult male |
| References |
Mufson MA, et al. A description of six new Rhinoviruses of human origin. Am. J. Epidemiol. 81: 32-43, 1965. PubMed: 14246079
|
